SD Head USA LLC

SD Head USA is the North American operations arm of Shandong Head Group Co., Ltd., a publicly listed Chinese enterprise founded in 1992 and traded on the Shenzhen Stock Exchange. The company has established itself as a premier global manufacturer of cellulose ethers and plant-based hydroxypropyl methylcellulose (HPMC) empty capsules, serving clients in over 60 countries across the Americas, Europe, Africa, Australia, and beyond. With a combined facility surface area of 290,000 square meters, a global workforce of more than 1,900 employees, and an annual manufacturing capacity of 75,000 metric tons of cellulose ether, the operation ranks among the largest of its kind in the world. SD Head USA was formally established in 2016 as a joint venture to provide localized services and direct market access to North American pharmaceutical, nutraceutical, food, and construction industry customers. The company's product portfolio is divided into two primary categories. The first is its Caps-Healsee® line of empty vegetarian HPMC capsules, designed for plant-based and vegan solid oral dosage forms in pharmaceutical and nutraceutical applications. This brand is recognized as one of the leading vegetarian capsule offerings globally, with a target capacity of 35 billion grains per year in development. The second major category is its Headcel line of cellulose ether derivatives, which includes hydroxypropyl methylcellulose (HPMC), methyl cellulose (MC), hydroxyethyl cellulose (HEC), methyl hydroxyethyl cellulose (MHEC), and ethyl cellulose, as well as specialty chemical intermediates such as diacetone acrylamide and adipic acid dihydrazide. These cellulose derivatives serve a versatile range of applications including pharmaceutical excipients, food ingredient systems, personal care formulations, and construction materials such as tile adhesives, renders, and dry-mix mortars. A key competitive differentiator is the company's vertically integrated supply chain, which enables tighter manufacturing controls, full chain-of-custody traceability, and minimal supply chain disruptions. The company employs a proprietary 'One Step' production method developed through its in-house Technical R&D center, launched in 2013, utilizing highly automated and closed production systems that ensure consistent product quality with minimal external variability. The parent group holds 88 patents as a result of ongoing R&D and technology investment. Quality and compliance are central to the company's value proposition. Its facilities are ISO 9001:2000 accredited, NSF-GMP approved, and certified Non-GMO, Halal, and Kosher — credentials that are particularly relevant to pharmaceutical and nutraceutical customers with strict formulation requirements. Products are distributed through multiple channels with door-to-door delivery options available, supported by a dedicated North American customer service team.

The Nombase Funding database has 4,288 records from over 1,788 companies.

There's no funding data for this company.